INS and steatosis: All of these pathways are supported by our previous evidence showing molecular perturbations to these pathways, and the physiological consequences including reduced fatty acid oxidation, deficient insulin signalling, liver inflammation and steatosis in Pcyt2 + /- mice [15,16] (Fig. 4B).